REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Transfusional Hemato Oncologico S.A.S. (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Corporate, Subsidiary, and Regional Managing Offices
Full name: Centro Transfusional Hemato Oncologico S.A.S. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro Transfusional Hemato Oncologico S.A.S. is an enterprise in Colombia, with the main office in Envigado. It operates in the Other Ambulatory Health Care Services industry. It was first established on May 11, 2018. There was a net sales revenue increase of 4.09% reported in Centro Transfusional Hemato Oncologico S.A.S.’s latest financial highlights for 2022. Its total assets grew by 137.76% over the same period. Centro Transfusional Hemato Oncologico S.A.S.’s net profit margin increased by 5.57% in 2022.

Headquarters
Cr 48 # 46A Sur 107
Envigado; Antioquia;

Contact Details: Purchase the Centro Transfusional Hemato Oncologico S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro Transfusional Hemato Oncologico S.A.S. report to view the information.
Incorporation Date:
May 11, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Centro Transfusional Hemato Oncologico S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
4.09%
Total operating revenue
4.09%
Net Profit (Loss) for the Period
28.48%
Total assets
137.76%
Total equity
127.79%
Net Profit Margin
5.57%
Return on Equity (ROE)
-43.37%
Quick Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?